Drug Profile
PF 4620110
Alternative Names: PF-04620110; PF-4620110Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antihyperglycaemics; Obesity therapies; Small molecules
- Mechanism of Action Diacylglycerol O acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 10 Nov 2011 Discontinued - Phase-I for Type-2 diabetes mellitus in Belgium (PO)
- 10 Nov 2011 Discontinued - Phase-I for Type-2 diabetes mellitus in Singapore (PO)
- 10 Nov 2011 Discontinued - Phase-I for Type-2 diabetes mellitus in USA (PO)